Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Epoetin-alfa Erythropoietin Industry: Supply and Demand, Markets and Prices 2021-2027

Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Epoetin-alfa Erythropoietin Market Status and Forecast (2016-2027)
      • 1.3.2 Global Epoetin-alfa Erythropoietin Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Epoetin-alfa Erythropoietin Supply by Company

    • 2.1 Global Epoetin-alfa Erythropoietin Sales Volume by Company
    • 2.2 Global Epoetin-alfa Erythropoietin Sales Value by Company
    • 2.3 Global Epoetin-alfa Erythropoietin Price by Company
    • 2.4 Epoetin-alfa Erythropoietin Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Epoetin-alfa Erythropoietin Market Status by Category

    • 3.1 Epoetin-alfa Erythropoietin Category Introduction
      • 3.1.1 Anemia
      • 3.1.2 Kidney Disorders
      • 3.1.3 Other
    • 3.2 Global Epoetin-alfa Erythropoietin Market by Category
      • 3.2.1 Global Epoetin-alfa Erythropoietin Sales Volume by Category (2016-2021)
      • 3.2.2 Global Epoetin-alfa Erythropoietin Sales Value by Category (2016-2021)
      • 3.2.3 Global Epoetin-alfa Erythropoietin Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Epoetin-alfa Erythropoietin Market Status by End User/Segment

    • 4.1 Epoetin-alfa Erythropoietin Segment by End User/Segment
      • 4.1.1 Hospital
      • 4.1.2 Clinic
    • 4.2 Global Epoetin-alfa Erythropoietin Market by End User/Segment
      • 4.2.1 Global Epoetin-alfa Erythropoietin Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Epoetin-alfa Erythropoietin Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Epoetin-alfa Erythropoietin Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Epoetin-alfa Erythropoietin Market Status by Region

    • 5.1 Global Epoetin-alfa Erythropoietin Market by Region
      • 5.1.1 Global Epoetin-alfa Erythropoietin Sales Volume by Region
      • 5.1.2 Global Epoetin-alfa Erythropoietin Sales Value by Region
    • 5.2 North America Epoetin-alfa Erythropoietin Market Status
    • 5.3 Europe Epoetin-alfa Erythropoietin Market Status
    • 5.4 Asia Pacific Epoetin-alfa Erythropoietin Market Status
    • 5.5 Central & South America Epoetin-alfa Erythropoietin Market Status
    • 5.6 Middle East & Africa Epoetin-alfa Erythropoietin Market Status

    6 North America Epoetin-alfa Erythropoietin Market Status

    • 6.1 North America Epoetin-alfa Erythropoietin Market by Country
      • 6.1.1 North America Epoetin-alfa Erythropoietin Sales Volume by Country (2016-2021)
      • 6.1.2 North America Epoetin-alfa Erythropoietin Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Epoetin-alfa Erythropoietin Market Status

    • 7.1 Europe Epoetin-alfa Erythropoietin Market by Country
      • 7.1.1 Europe Epoetin-alfa Erythropoietin Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Epoetin-alfa Erythropoietin Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Epoetin-alfa Erythropoietin Market Status

    • 8.1 Asia Pacific Epoetin-alfa Erythropoietin Market by Country
      • 8.1.1 Asia Pacific Epoetin-alfa Erythropoietin Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Epoetin-alfa Erythropoietin Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Epoetin-alfa Erythropoietin Market Status

    • 9.1 Central & South America Epoetin-alfa Erythropoietin Market by Country
      • 9.1.1 Central & South America Epoetin-alfa Erythropoietin Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Epoetin-alfa Erythropoietin Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Epoetin-alfa Erythropoietin Market Status

    • 10.1 Middle East & Africa Epoetin-alfa Erythropoietin Market by Country
      • 10.1.1 Middle East & Africa Epoetin-alfa Erythropoietin Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Epoetin-alfa Erythropoietin Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Epoetin-alfa Erythropoietin Manufacturing Cost Analysis
    • 11.5 Epoetin-alfa Erythropoietin Sales Channel and Distributors Analysis
      • 11.5.1 Epoetin-alfa Erythropoietin Sales Channel
      • 11.5.2 Epoetin-alfa Erythropoietin Distributors
    • 11.6 Epoetin-alfa Erythropoietin Downstream Major Buyers

    12 Global Epoetin-alfa Erythropoietin Market Forecast by Category and by End User/Segment

    • 12.1 Global Epoetin-alfa Erythropoietin Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Epoetin-alfa Erythropoietin Forecast by Category
      • 12.2.1 Global Epoetin-alfa Erythropoietin Sales Volume Forecast by Category
      • 12.2.2 Global Epoetin-alfa Erythropoietin Sales Value Forecast by Category
      • 12.2.3 Global Epoetin-alfa Erythropoietin Price Forecast by Category
    • 12.3 Global Epoetin-alfa Erythropoietin Forecast by End User/Segment
      • 12.3.1 Global Epoetin-alfa Erythropoietin Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Epoetin-alfa Erythropoietin Sales Value Forecast by End User/Segment
      • 12.3.3 Global Epoetin-alfa Erythropoietin Price Forecast by End User/Segment

    13 Global Epoetin-alfa Erythropoietin Market Forecast by Region/Country

    • 13.1 Global Epoetin-alfa Erythropoietin Market Forecast by Region (2022-2027)
      • 13.1.1 Global Epoetin-alfa Erythropoietin Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Epoetin-alfa Erythropoietin Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Roche
      • 14.1.1 Company Information
      • 14.1.2 Epoetin-alfa Erythropoietin Product Introduction
      • 14.1.3 Roche Epoetin-alfa Erythropoietin Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 LG Life Sciences
      • 14.2.1 Company Information
      • 14.2.2 Epoetin-alfa Erythropoietin Product Introduction
      • 14.2.3 LG Life Sciences Epoetin-alfa Erythropoietin Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Kyowa Hakko Kirin
      • 14.3.1 Company Information
      • 14.3.2 Epoetin-alfa Erythropoietin Product Introduction
      • 14.3.3 Kyowa Hakko Kirin Epoetin-alfa Erythropoietin Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Johnson & Johnson
      • 14.4.1 Company Information
      • 14.4.2 Epoetin-alfa Erythropoietin Product Introduction
      • 14.4.3 Johnson & Johnson Epoetin-alfa Erythropoietin Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Galenica
      • 14.5.1 Company Information
      • 14.5.2 Epoetin-alfa Erythropoietin Product Introduction
      • 14.5.3 Galenica Epoetin-alfa Erythropoietin Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Emcure
      • 14.6.1 Company Information
      • 14.6.2 Epoetin-alfa Erythropoietin Product Introduction
      • 14.6.3 Emcure Epoetin-alfa Erythropoietin Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Biocon
      • 14.7.1 Company Information
      • 14.7.2 Epoetin-alfa Erythropoietin Product Introduction
      • 14.7.3 Biocon Epoetin-alfa Erythropoietin Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Amgen
      • 14.8.1 Company Information
      • 14.8.2 Epoetin-alfa Erythropoietin Product Introduction
      • 14.8.3 Amgen Epoetin-alfa Erythropoietin Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 3SBio
      • 14.9.1 Company Information
      • 14.9.2 Epoetin-alfa Erythropoietin Product Introduction
      • 14.9.3 3SBio Epoetin-alfa Erythropoietin Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Epoetin-alfa Erythropoietin market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Epoetin-alfa Erythropoietin market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Anemia
      Kidney Disorders
      Other

      Segmented by End User/Segment
      Hospital
      Clinic

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Roche
      LG Life Sciences
      Kyowa Hakko Kirin
      Johnson & Johnson
      Galenica
      Emcure
      Biocon
      Amgen
      3SBio

      Buy now